Armata Pharmaceuticals (ARMP) Amortizatization of Intangibles (2013 - 2014)
Armata Pharmaceuticals (ARMP) posted Amortizatization of Intangibles of $8000.0 for Q1 2014, up 900.0% sequentially from -$1000.0 in Q4 2013, and down 97.43% YoY from $311000.0 in Q1 2013.
Armata Pharmaceuticals (ARMP) Amortizatization of Intangibles (2013 - 2014) Analysis & Trends
Armata Pharmaceuticals has reported Amortizatization of Intangibles for 2 years, with the latest figure at $8000.0 in Q1 2014.
- Quarterly Amortizatization of Intangibles fell 97.43% year-over-year to $8000.0 in Q1 2014, while the trailing twelve-month figure through Dec 2014 was $8000.0 (down 99.7% YoY) and the FY2013 annual result came in at $2.6 million, changed N/A from the prior year.
- Amortizatization of Intangibles grew to $8000.0 in Q1 2014 per ARMP's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $2.3 million in Q2 2013 and troughed at -$1000.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 8,000.00 |
| Mar 31, 2014 | 8,000.00 |
| Dec 31, 2013 | -1,000.00 |
| Dec 31, 2013 | -1,000.00 |
| Jun 30, 2013 | 2.33 Mn |
| Jun 30, 2013 | 2.33 Mn |
| Mar 31, 2013 | 311,000.00 |
| Mar 31, 2013 | 311,000.00 |